Download PDF
Semin Neurol
DOI: 10.1055/s-0044-1791770
Review Article

Pharmacologic and Nonpharmacologic Management of Neuropathic Pain

Andrew Feldman
1   Department of Neurology, Weill Cornell Medical Center/New York Presbyterian Hospital, New York, New York
,
Joshua Weaver
1   Department of Neurology, Weill Cornell Medical Center/New York Presbyterian Hospital, New York, New York
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Disorders of the somatosensory nervous system that cause neuropathic pain are treated in a variety of ways. Herein, we introduce a stepwise approach to treating neuropathic pain. We then summarize the available data and guidelines for treating neuropathic pain, both with pharmacologic and nonpharmacologic methods, and provide a synthesized algorithm highlighting the similarities and differences between recent guidelines on the management of neuropathic pain. Pharmacologic treatments are primarily antiseizure medications (e.g., gabapentinoids, sodium channel blockers) and antidepressant medications (e.g., tricyclic antidepressants, serotonin–norepinephrine reuptake inhibitors), though other medications and interventional pharmacologic therapies can also be considered. There are a wide variety of nonpharmacologic treatments for neuropathic pain including neuromodulation, nerve stimulation, physiotherapy, movement therapies, lifestyle modification, nutritional supplements, acupuncture, and mind–body techniques.

Keywords

neuropathic pain - pharmacologic therapy - nonpharmacologic therapy - complementary and alternative medicine - integrative medicine


Publication History

Article published online:
11 October 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Jensen TS, Baron R, Haanpää M. et al. A new definition of neuropathic pain. Pain 2011; 152 (10) 2204-2205
    CrossrefPubMedSearch in Google Scholar
  • 2 Zhou M, Chen N, He L, Yang M, Zhu C, Wu F. Oxcarbazepine for neuropathic pain. Cochrane Database Syst Rev 2017; 12 (12) CD007963
    PubMedSearch in Google Scholar
  • 3 Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; 150 (03) 573-581
    CrossrefPubMedSearch in Google Scholar
  • 4 Malhotra A, Weaver J. Approach to neuropathic pain. Semin Neurol 2021; 41 (06) 744-759
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Lambru G, Zakrzewska J, Matharu M. Trigeminal neuralgia: a practical guide. Pract Neurol 2021; 21 (05) 392-402
    CrossrefPubMedSearch in Google Scholar
  • 6 D'Souza RS, Barman R, Joseph A, Abd-Elsayed A. Evidence-based treatment of painful diabetic neuropathy: a systematic review. Curr Pain Headache Rep 2022; 26 (08) 583-594
    CrossrefPubMedSearch in Google Scholar
  • 7 Zilliox LA. Neuropathic pain. Continuum (Minneap Minn) 2017; 23 (2, Selected Topics in Outpatient Neurology): 512-532
    PubMedSearch in Google Scholar
  • 8 Finnerup NB, Attal N, Haroutounian S. et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14 (02) 162-173
    CrossrefPubMedSearch in Google Scholar
  • 9 Bates D, Schultheis BC, Hanes MC. et al. A comprehensive algorithm for management of neuropathic pain. Pain Med 2019; 20 (Suppl. 01) S2-S12
    CrossrefPubMedSearch in Google Scholar
  • 10 Szok D, Tajti J, Nyári A, Vécsei L. Therapeutic approaches for peripheral and central neuropathic pain. Behav Neurol 2019; 2019: 8685954
    CrossrefPubMedSearch in Google Scholar
  • 11 Ryan R, Hill S. How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group. 2016 . Accessed September 26, 2024 at: http://cccrg.cochrane.org/author-resources . Version 3.0 December 2016
    PubMedSearch in Google Scholar
  • 12 Deng Y, Luo L, Hu Y, Fang K, Liu J. Clinical practice guidelines for the management of neuropathic pain: a systematic review. BMC Anesthesiol 2016; 16: 12
    CrossrefPubMedSearch in Google Scholar
  • 13 Moisset X, Bouhassira D, Avez Couturier J. et al. Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev Neurol (Paris) 2020; 176 (05) 325-352
    CrossrefPubMedSearch in Google Scholar
  • 14 Moulin D, Boulanger A, Clark AJ. et al; Canadian Pain Society. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res Manag 2014; 19 (06) 328-335
    CrossrefPubMedSearch in Google Scholar
  • 15 Price R, Smith D, Franklin G. et al. Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN guideline subcommittee. Neurology 2022; 98 (01) 31-43
    CrossrefPubMedSearch in Google Scholar
  • 16 Chincholkar M. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. Br J Pain 2020; 14 (02) 104-114
    CrossrefPubMedSearch in Google Scholar
  • 17 Wiffen PJ, Derry S, Bell RF. et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2017; 6 (06) CD007938
    CrossrefPubMedSearch in Google Scholar
  • 18 Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev 2019; 1 (01) CD007076
    PubMedSearch in Google Scholar
  • 19 Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol 2019; 33: 2058738419838383
    CrossrefPubMedSearch in Google Scholar
  • 20 Thour A, Marwaha R. Amitriptyline. [Updated 2023 Jul 18]. In: StatPearls [Internet]. Treasure Island, FL:: StatPearls Publishing;; 2024
    Search in Google Scholar
  • 21 Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Intern Med 2019; 179 (08) 1084-1093
    CrossrefPubMedSearch in Google Scholar
  • 22 Liu WQ, Kanungo A, Toth C. Equivalency of tricyclic antidepressants in open-label neuropathic pain study. Acta Neurol Scand 2014; 129 (02) 132-141
    CrossrefPubMedSearch in Google Scholar
  • 23 Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database Syst Rev 2015; 2015 (07) CD008242
    PubMedSearch in Google Scholar
  • 24 Derry S, Wiffen PJ, Aldington D, Moore RA. Nortriptyline for neuropathic pain in adults. Cochrane Database Syst Rev 2015; 1 (01) CD011209
    PubMedSearch in Google Scholar
  • 25 Hearn L, Moore RA, Derry S, Wiffen PJ, Phillips T. Desipramine for neuropathic pain in adults. In: The Cochrane Collaboration, ed. Cochrane Database of Systematic Reviews: Protocols. John Wiley & Sons, Ltd;; 1996.
    CrossrefSearch in Google Scholar
  • 26 Hearn L, Derry S, Phillips T, Moore RA, Wiffen PJ. Imipramine for neuropathic pain in adults. Cochrane Database Syst Rev 2014; 2014 (05) CD010769
    PubMedSearch in Google Scholar
  • 27 D'Souza RS, Alvarez GAM, Dombovy-Johnson M, Eller J, Abd-Elsayed A. Evidence-based treatment of pain in chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep 2023; 27 (05) 99-116
    CrossrefPubMedSearch in Google Scholar
  • 28 Lunn MPT, Hughes RAC, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst Rev 2014; 2014 (01) CD007115
    PubMedSearch in Google Scholar
  • 29 Gallagher HC, Gallagher RM, Butler M, Buggy DJ, Henman MC. Venlafaxine for neuropathic pain in adults. Cochrane Database Syst Rev 2015; 2015 (08) CD011091
    PubMedSearch in Google Scholar
  • 30 Aiyer R, Barkin RL, Bhatia A. Treatment of neuropathic pain with venlafaxine: a systematic review. Pain Med 2017; 18 (10) 1999-2012
    PubMedSearch in Google Scholar
  • 31 Demant DT, Lund K, Finnerup NB. et al. Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study. Pain 2015; 156 (11) 2234-2244
    CrossrefPubMedSearch in Google Scholar
  • 32 Colloca L, Ludman T, Bouhassira D. et al. Neuropathic pain. Nat Rev Dis Primers 2017; 3: 17002
    CrossrefPubMedSearch in Google Scholar
  • 33 Vinik AI, Perrot S, Vinik EJ. et al. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study. BMC Neurol 2016; 16 (01) 251
    CrossrefPubMedSearch in Google Scholar
  • 34 Balanaser M, Carley M, Baron R. et al. Combination pharmacotherapy for the treatment of neuropathic pain in adults: systematic review and meta-analysis. Pain 2023; 164 (02) 230-251
    CrossrefPubMedSearch in Google Scholar
  • 35 Tesfaye S, Sloan G, Petrie J. et al; OPTION-DM Trial Group. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Lancet 2022; 400 (10353): 680-690
    CrossrefPubMedSearch in Google Scholar
  • 36 Chaparro LE, Wiffen PJ, Moore RA, Gilron I. Combination pharmacotherapy for the treatment of neuropathic pain in adults. Cochrane Database Syst Rev 2012; 2012 (07) CD008943
    PubMedSearch in Google Scholar
  • 37 Niesters M, Proto PL, Aarts L, Sarton EY, Drewes AM, Dahan A. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Br J Anaesth 2014; 113 (01) 148-156
    CrossrefPubMedSearch in Google Scholar
  • 38 Arthur P, Kalvala A, Surapaneni S, Sachdeva M. Applications of cannabinoids in neuropathic pain: an updated review. Crit Rev Ther Drug Carrier Syst 2022;
    CrossrefPubMedSearch in Google Scholar
  • 39 Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2018; 3 (03) CD012182
    CrossrefPubMedSearch in Google Scholar
  • 40 Wallace MS, Marcotte TD, Umlauf A, Gouaux B, Atkinson JH. Efficacy of inhaled cannabis on painful diabetic neuropathy. J Pain 2015; 16 (07) 616-627
    CrossrefPubMedSearch in Google Scholar
  • 41 Johal H, Devji T, Chang Y, Simone J, Vannabouathong C, Bhandari M. Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord 2020; 13: 1179544120906461
    CrossrefPubMedSearch in Google Scholar
  • 42 Jeffers AM, Glantz S, Byers AL, Keyhani S. Association of cannabis use with cardiovascular outcomes among US adults. J Am Heart Assoc 2024; 13 (05) e030178
    CrossrefPubMedSearch in Google Scholar
  • 43 Wiffen PJ, Derry S, Moore RA, Kalso EA. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014; 2014 (04) CD005451
    PubMedSearch in Google Scholar
  • 44 Wiffen PJ, Derry S, Moore RA. Lamotrigine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2013; 2013 (12) CD006044
    PubMedSearch in Google Scholar
  • 45 Wiffen PJ, Derry S, Lunn MPT, Moore RA. Topiramate for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2013; 2013 (08) CD008314
    PubMedSearch in Google Scholar
  • 46 Birse F, Derry S, Moore RA. Phenytoin for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012; 2012 (05) CD009485
    PubMedSearch in Google Scholar
  • 47 Hearn L, Derry S, Moore RA. Lacosamide for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2012; 2012 (02) CD009318
    PubMedSearch in Google Scholar
  • 48 Moore RA, Wiffen PJ, Derry S, Lunn MPT. Zonisamide for neuropathic pain in adults. Cochrane Database Syst Rev 2015; 1 (01) CD011241
    PubMedSearch in Google Scholar
  • 49 Cooper TE, Chen J, Wiffen PJ. et al. Morphine for chronic neuropathic pain in adults. Cochrane Database Syst Rev 2017; 5 (05) CD011669
    PubMedSearch in Google Scholar
  • 50 Shaygan M, Böger A, Kröner-Herwig B. Predicting factors of outcome in multidisciplinary treatment of chronic neuropathic pain. J Pain Res 2018; 11: 2433-2443
    CrossrefPubMedSearch in Google Scholar
  • 51 Chen L, Michalsen A. Management of chronic pain using complementary and integrative medicine. BMJ 2017; 357: j1284
    CrossrefPubMedSearch in Google Scholar
  • 52 Kandah M, Wilson C, Pilitsis JG. Role of integrative health on neuropathic pain. Curr Pain Headache Rep 2023; 27 (04) 49-55
    CrossrefPubMedSearch in Google Scholar
  • 53 Petersen EA, Stauss TG, Scowcroft JA. et al. Effect of high-frequency (10-kHz) spinal cord stimulation in patients with painful diabetic neuropathy: a randomized clinical trial. JAMA Neurol 2021; 78 (06) 687-698
    CrossrefPubMedSearch in Google Scholar
  • 54 Ju ZY, Wang K, Cui HS. et al. Acupuncture for neuropathic pain in adults. Cochrane Database Syst Rev 2017; 12 (12) CD012057
    PubMedSearch in Google Scholar
  • 55 Choi GH, Wieland LS, Lee H, Sim H, Lee MS, Shin BC. Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome. Cochrane Database Syst Rev 2018; 12 (12) CD011215
    PubMedSearch in Google Scholar
  • 56 Mu J, Furlan AD, Lam WY, Hsu MY, Ning Z, Lao L. Acupuncture for chronic nonspecific low back pain. Cochrane Database Syst Rev 2020; 12 (12) CD013814
    CrossrefPubMedSearch in Google Scholar
  • 57 He K, Hu R, Huang Y, Qiu B, Chen Q, Ma R. Effects of acupuncture on neuropathic pain induced by spinal cord injury: a systematic review and meta-analysis. Evid Based Complement Alternat Med 2022; 2022: 6297484
    PubMedSearch in Google Scholar
  • 58 Nielsen A, Wieland LS. Cochrane reviews on acupuncture therapy for pain: a snapshot of the current evidence. Explore (NY) 2019; 15 (06) 434-439
    CrossrefPubMedSearch in Google Scholar
  • 59 Dimitrova A, Murchison C, Oken B. Acupuncture for the treatment of peripheral neuropathy: a systematic review and meta-analysis. J Altern Complement Med 2017; 23 (03) 164-179
    CrossrefPubMedSearch in Google Scholar
  • 60 Rowin J. Integrative neuromuscular medicine: neuropathy and neuropathic pain: Consider the alternatives. Muscle Nerve 2019; 60 (02) 124-136
    CrossrefPubMedSearch in Google Scholar
  • 61 Li X, Liu Y, Jing Z. et al. Effects of acupuncture therapy in diabetic neuropathic pain: a systematic review and meta-analysis. Complement Ther Med 2023; 78: 102992
    CrossrefPubMedSearch in Google Scholar
  • 62 Zhou L, Wu T, Zhong Z, Yi L, Li Y. Acupuncture for painful diabetic peripheral neuropathy: a systematic review and meta-analysis. Front Neurol 2023; 14: 1281485
    CrossrefPubMedSearch in Google Scholar
  • 63 Williams ACC, Fisher E, Hearn L, Eccleston C. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev 2020; 8 (08) CD007407
    CrossrefPubMedSearch in Google Scholar
  • 64 Inoue M, Inoue S, Ikemoto T. et al. The efficacy of a multidisciplinary group program for patients with refractory chronic pain. Pain Res Manag 2014; 19 (06) 302-308
    CrossrefPubMedSearch in Google Scholar
  • 65 Smith JG, Knight L, Stewart A, Smith EL, McCracken LM. Clinical effectiveness of a residential pain management programme - comparing a large recent sample with previously published outcome data. Br J Pain 2016; 10 (01) 46-58
    CrossrefPubMedSearch in Google Scholar
  • 66 Twiddy H, Frank B, Alam U. A consideration of the psychological aspects to managing patients with painful diabetic neuropathy: an insight into pain management services at a tertiary centre in the UK. Diabetes Ther 2021; 12 (02) 487-498
    CrossrefPubMedSearch in Google Scholar
  • 67 Langlois P, Perrochon A, David R. et al. Hypnosis to manage musculoskeletal and neuropathic chronic pain: a systematic review and meta-analysis. Neurosci Biobehav Rev 2022; 135: 104591
    CrossrefPubMedSearch in Google Scholar
  • 68 Zheng RX, Xu JW, Jiang BY. et al. Mind-body therapies in traditional Chinese medicine for neuropathic pain: a systematic review of randomized controlled trials. Pain Manag Nurs 2023; 24 (02) 157-170
    CrossrefPubMedSearch in Google Scholar
  • 69 Bhardwaj P, Ahuja N, Parchani A, Singh S, Sethi D, Pathania M. Yoga as a complementary therapy in neuropathic pain: a systematic review and meta-analysis of randomized controlled trials. J Family Med Prim Care 2023; 12 (10) 2214-2222
    CrossrefPubMedSearch in Google Scholar
  • 70 Cooper MA, Kluding PM, Wright DE. Emerging relationships between exercise, sensory nerves, and neuropathic pain. Front Neurosci 2016; 10: 372
    CrossrefPubMedSearch in Google Scholar
  • 71 Paley CA, Johnson MI. Physical activity to reduce systemic inflammation associated with chronic pain and obesity: a narrative review. Clin J Pain 2016; 32 (04) 365-370
    CrossrefPubMedSearch in Google Scholar
  • 72 Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH. Physical activity and exercise for chronic pain in adults: an overview of Cochrane reviews. Cochrane Database Syst Rev 2017; 4 (04) CD011279
    PubMedSearch in Google Scholar
  • 73 Bidonde J, Busch AJ, Schachter CL. et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst Rev 2017; 6 (06) CD012700
    PubMedSearch in Google Scholar
  • 74 Bidonde J, Busch AJ, Webber SC. et al. Aquatic exercise training for fibromyalgia. Cochrane Database Syst Rev 2014; 2014 (10) CD011336
    PubMedSearch in Google Scholar
  • 75 Tatikola SP, Natarajan V, Desai VK, Asirvatham AR, Rajsekhar H. Effect of various exercise protocols on neuropathic pain in individuals with type 2 diabetes with peripheral neuropathy: a systematic review and meta-analysis. Diabetes Metab Syndr 2022; 16 (09) 102603
    CrossrefPubMedSearch in Google Scholar
  • 76 Allison DJ, Thomas A, Beaudry K, Ditor DS. Targeting inflammation as a treatment modality for neuropathic pain in spinal cord injury: a randomized clinical trial. J Neuroinflammation 2016; 13 (01) 152
    CrossrefPubMedSearch in Google Scholar
  • 77 Ilari S, Proietti S, Russo P. et al. A systematic review and meta-analysis on the role of nutraceuticals in the management of neuropathic pain in in vivo studies. Antioxidants 2022; 11 (12) 2361
    CrossrefPubMedSearch in Google Scholar
  • 78 Boyd A, Bleakley C, Hurley DA. et al. Herbal medicinal products or preparations for neuropathic pain. Cochrane Database Syst Rev 2019; 4 (04) CD010528
    PubMedSearch in Google Scholar
  • 79 Frediani JK, Lal AA, Kim E, Leslie SL, Boorman DW, Singh V. The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: a systematic review. Pain Pract 2024; 24 (01) 186-210
    CrossrefPubMedSearch in Google Scholar
  • 80 Basu P, Maier C, Basu A. Effects of curcumin and its different formulations in preclinical and clinical studies of peripheral neuropathic and postoperative pain: a comprehensive review. Int J Mol Sci 2021; 22 (09) 4666
    CrossrefPubMedSearch in Google Scholar
  • 81 Caillaud M, Aung Myo YP, McKiver BD. et al. Key developments in the potential of curcumin for the treatment of peripheral neuropathies. Antioxidants 2020; 9 (10) 950
    CrossrefPubMedSearch in Google Scholar